CKMT2 and cancer: Chen et al. (2022) classified CRC into different metabolic subgroups and found high expression of CKMT2 in patients with the glycolytic subtype, suggesting that CKMT2 may play a regulatory role in cancer cell proliferation and tumorigenesis through the glycolytic pathway.